Synthetic Biologics, Inc.’s (SYN) Stock Keeps On Rising

The SYN stock price fluctuated between $0.492 and $0.5159 throughout the trading session with the volume trading being 1M shares, which represented a negative variation when compared to the three months average volume of 3M shares.

The share price of Synthetic Biologics, Inc. (NYSE:SYN) ran up 1.11% to close Wednesday’s market session at $0.5116, higher as compared to yesterday’s close which brings the market valuation of the company to $67.55M.

The 52-week high for the Synthetic Biologics, Inc.’s shares is $1.7000. That puts it -69.91% from that peak but still an impressive gain since the share price dropped to a 52-week low of $0.2600, while the S&P 500’s share price change was of 35.08%.

What does the trading volume tell us about the SYN stock?

During the last trading session, Synthetic Biologics, Inc. (NYSE American:SYN) has seen decay in its daily volume. The daily volume was of 3M, while in the last 10 days the average was 1.61M and last three months – 2.73M.
The increasing interest in the SYN stock from the investors is helping to drive the stock price up.

Growing short interest

The Synthetic Biologics, Inc.’s shares are seeing an increasing short interest compared to the previous month. As of today, there are 106.85k shares being shorted which translates into 0.05 of a short ratio for SYN, while in the previous month the shorted shares were 812.13k.

Synthetic Biologics, Inc. (NYSE:SYN) financials

With a market cap of 67.55M, Synthetic Biologics, Inc. holds a total cash of $76.89M that translates into $0.29 per share, while the total debt is of $405k.